Skip to main content

Day: December 13, 2022

MeiraGTx Announces Positive Clinical Data from the AQUAx Phase 1 Clinical Study of AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia

Clinically meaningful improvements in xerostomia symptoms and disease burden reported in patient reported outcome (PRO) measures in both unilateral and bilateral cohortsIncreases in whole saliva flow rates were seen in both unilateral and bilateral cohortsOverall degree of improvement was greater in bilateral compared to unilateral cohortsAAV2-hAQP1 appears safe and well tolerated at each dose testedWebcast and conference call to be held today, December 13, 2022, at 8:00 a.m. ETLONDON and NEW YORK, Dec. 13, 2022 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced positive clinical data from the ongoing Phase 1 AQUAx study of AAV2-hAQP1 for the treatment of grade 2/3 radiation-induced xerostomia (RIX). “We are very encouraged by the...

Continue reading

American Airlines Names Devon May Chief Financial Officer

Derek Kerr to Step Down From CFO Role at End of Year Following Long-Planned Succession Process; Kerr to Remain at American as Vice Chair, President of American Eagle and Strategic AdvisorAmerican Airlines Names Devon May Chief Financial Officer American Airlines Names Devon May Chief Financial OfficerFORT WORTH, Texas, Dec. 13, 2022 (GLOBE NEWSWIRE) — American Airlines Group Inc. (NASDAQ: AAL) today announced that Devon May has been named Chief Financial Officer following a long-planned succession process. May, who is currently the airline’s senior vice president of Finance and Investor Relations, will assume the CFO role effective Jan. 1, 2023. He will report to American’s CEO Robert Isom. American’s current CFO Derek Kerr will remain at the airline as Vice Chair, President of American Eagle and Strategic Advisor. He will...

Continue reading

Rapid Therapeutic Science Laboratories Updates Patents

DALLAS, Dec. 13, 2022 (GLOBE NEWSWIRE) — Rapid Therapeutics Science Laboratories (OTC: RTSL) (“Rapid Therapeutic” or the “Company”), a growth-oriented aerosol manufacturing company focused on natural relief innovations through trusted aerosol delivery, announces today that it has moved three (3) proprietary pharmaceutical grade patents from provisional to non-provisional status. Donal R. Schmidt, Jr. CEO states: “All three patent applications are specially designed for inhalation of CBD and CBG with the expectation they will eventually be approved by the FDA for delivery in a pressurized metered dose inhaler (pMDI).” RTSL previously marketed both CBD and CBG delivered in MDI through pharmacies and physicians before removing them from the public market to focus on research and FDA approval of its inhaled...

Continue reading

Gritstone bio Granted Two New U.S. Patents for Self-amplifying mRNA (samRNA)

— Patents support Gritstone’s pioneering work in the application of next-generation samRNA vaccine technology in oncology and infectious disease — EMERYVILLE, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that the United States Patent and Trademark Office (USPTO) recently issued two new patents related to the company’s novel self-amplifying mRNA (samRNA) vaccine platform technology. U.S. Patent No. 11,504,421 includes claims covering Gritstone’s individualized cancer vaccine candidates (GRANITE). U.S. Patent No. 11,510,973 includes claims covering antigen-encoding samRNA vectors and has broad applicability across Gritstone’s candidates in oncology and infectious disease. “Self-amplifying...

Continue reading

Timbercreek Financial Comments on Group Sélection Loans

Toronto Stock Exchange: TF TORONTO, Dec. 13, 2022 (GLOBE NEWSWIRE) — Timbercreek Financial Corp. (TSX: TF) (the “Company” or “Timbercreek Financial”) today provided commentary and clarification on its loans to Groupe Sélection Inc. (“Groupe Sélection”), one of Canada’s largest private companies in the retirement community sector. On November 13, 2022, Groupe Sélection filed an application under the Companies’ Creditors Arrangement Act (CCAA) in order to proceed with a restructuring. Several recent media articles have stated that Timbercreek’s investments to Groupe Sélection total approximately $212 million. Timbercreek is in the business of originating commercial mortgages and often works with third-party lenders to share loans based on different risk and return criteria. This total amount represents the gross amount of the first...

Continue reading

Fluence to Design and Manufacture Battery Packs as Part of Storage Products

Fluence-made battery packs, to be developed in the U.S., will allow greater global supply chain flexibility to best serve customers with rapid energy storage deployment ARLINGTON, Va., Dec. 13, 2022 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a leading global provider of energy storage products, services, and cloud-based software for renewables and storage, today announced a strategic plan to develop Fluence-made battery packs, with production set to begin in early 2024 in the United States. The move is intended to give Fluence greater control over the global supply chain and increase standardization across products. Moreover, we believe that this plan to develop and introduce Fluence-made battery packs will assist Fluence customers in accessing incentives under the Inflation Reduction Act of 2022. The Fluence-designed...

Continue reading

Green Thumb Industries Announces Expansion of Executive Leadership Team

Executive Management and Board Member Appointments to Take Effect January 1, 2023 CHICAGO and VANCOUVER, British Columbia, Dec. 13, 2022 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced the appointments of four executive leadership positions and one new board member. The leadership promotions include Anthony Georgiadis to President, Matt Faulkner to Chief Financial Officer, and Bret Kravitz to General Counsel and Secretary, as well as the appointments of Rachel Albert to Chief Administrative Officer and Dawn Wilson Barnes to the Company’s board of directors. These appointments will be effective January 1, 2023. “These changes reflect the natural evolution of high-performing team members...

Continue reading

Marker Therapeutics and Lincoln Park Capital Enter into a Common Stock Purchase Agreement for up to $25 Million

HOUSTON, Dec. 13, 2022 (GLOBE NEWSWIRE) — Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that the Company has entered into a Common Stock Purchase Agreement (the “Agreement”) for up to $25 million with Lincoln Park Capital Fund (“LPC”), a Chicago-based institutional investor and long-term Marker shareholder. Under the terms of the Agreement, LPC has committed to purchase up to $25 million of shares of the Company’s common stock at Marker’s sole discretion from time to time during a 24-month period upon satisfaction of the conditions in the Agreement, including after a registration statement...

Continue reading

XPO Named One of America’s Most Responsible Companies for 2023 by Newsweek

GREENWICH, Conn. , Dec. 13, 2022 (GLOBE NEWSWIRE) — XPO (NYSE: XPO), a leading provider of less-than-truckload transportation in North America, has been named by Newsweek as one of America’s Most Responsible Companies for a third year.  Newsweek, one of the nation’s oldest business publications, selects the most responsible US public companies in partnership with research firm Statista. The two organizations analyze 2,000 candidates using more than 30 key performance indicators, publicly available information and a reputational survey of US residents. Mario Harik, XPO’s chief executive officer, said, “This recognition means a great deal to us, because Newsweek considers the full scope of corporate responsibility in making its determination. The social and environmental aspects of our culture are valued by our customers as reasons...

Continue reading

Consolidated Uranium Announces Mineral Resource Estimate for the Tony M Mine

Figure 1 Location Map: Tony M Mine, Utah in proximity to the White Mesa MillFigure 2 Tony M Mine 2022 Drilling and Resource OutlineTORONTO, Dec. 13, 2022 (GLOBE NEWSWIRE) — Consolidated Uranium, Inc. (TSXV:CUR) (OTCQB: CURUF) (“CUR”, “Consolidated Uranium”, the “Company”) is pleased to announce the completion of a confirmation drill program and a mineral resource estimate and supporting technical report prepared in accordance with NI 43-101 at the Company’s 100%-owned Tony M mine (the “Technical Report”). The Technical Report was prepared by the independent consulting firm SLR International Corporation (“SLR”) and has been filed under the Company’s profile on SEDAR. HighlightsThe Mineral Resource estimate is based upon a commodity price of US$65.00 per pound of U3O8, and a cut-off grade of 0.14% eU3O8 are reported as an:Indicated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.